MGTX — MeiraGTx Holdings PLC
NASDAQ · Biotechnology · Biotechnology
- Latest Close
- $9.23
- 30-Day Move
- +3.7%
- Market Cap
- $739M
- Shares Outstanding
- 80,490,000
- P/B Ratio
- 7.02
- ROE
- -217.9%
Analyst consensus: Buy · 14 analysts
MeiraGTx Holdings PLC
A read-only Alphactor snapshot forMeiraGTx Holdings PLC. It uses the same research structure as the app, but with delayed data and shallow depth so search visitors can evaluate the stock before signing up.
Snapshot as of2026-04-25
Topline snapshot
Latest Close
$9.23
30-Day Move
+3.7%
Market Cap
$739M
Shares Outstanding
80,490,000
P/B Ratio
7.02
ROE
-217.9%
$9.23
+3.7%last 90 delayed daily bars
90D High
$11.85
90D Low
$6.62
Avg Volume
583,002
Gross margin is running at 94.0%, which gives a quick read on operating quality before you open the full model.
Net margin is -140.3%, useful for comparing MGTX against peers in Biotechnology.
MGTX is up 3.7% over the last 30 trading days shown on this page.
Latest operating income is $26M, which helps anchor the headline ratios with an actual earnings figure.
Composite Fair Value
$4.77
Rule of 40
82.4%
Dark Pool Short %
39.2%
Search Interest
0
Latest Close
$9.23
30-Day Move
+3.7%
Market Cap
$739M
Shares Outstanding
80,490,000
P/B Ratio
7.02
ROE
-217.9%
ROA
-46.7%
Gross Margin
94.0%
Operating Margin
-130.2%
Net Margin
-140.3%
Debt / Equity
1.08
Current Ratio
0.75
Latest Revenue
$75M
Revenue
$75M
Gross Profit
$75M
Operating Income
$26M
Net Income
$15M
Gross Margin
9405.0%
Net Margin
-14031.0%
Current Ratio
0.75
Debt / Equity
1.08
Fair Value
$4.77
Upside / Downside
-48.3%
Signal
Overvalued
Implied Growth
--
EV/Rev
$4.77
Growth Assumption
50.0%
Discount Rate
10.1%
Terminal Growth
2.0%
Base FCF
--
Valuation spread
After signup
The full valuation workspace goes deeper
Adjust DCF growth, discount, and terminal assumptions instead of relying on one static snapshot.
Open the deeper balance-sheet and cash-flow views to inspect debt, liquidity, and cash generation line by line.
Compare multiple valuation models against peers and save your own thesis instead of re-reading a fixed public state.
Negative FCF — company is cash-flow negative. Reverse DCF requires positive cash flows.
Altman Z
-4.15
Distress
Piotroski
4
Moderate (4-6)
Cash Conversion
0.41x
Rule of 40
82.4%
Elite
Annual performance mix
| Period | Revenue | Operating Income | Net Income | Free Cash Flow |
|---|---|---|---|---|
| 2022-12-31 | $16M | $-116M | $-130M | $-118M |
| 2023-12-31 | $14M | $-137M | $-84M | $-126M |
| 2024-12-31 | $33M | $-164M | $-148M | $-109M |
| 2025-12-31 | $81M | $-106M | $-114M | $-51M |
After signup
The app opens the full statement deep dive
Extend the history well beyond this public snapshot to inspect longer cycles and regime changes.
Move from summary lines into detailed balance-sheet and cash-flow rows for working capital, debt, and capex analysis.
Cross-link statement changes with alerts, watchlists, and saved research workflows after signup.
After signup
The full sentiment workspace adds context
Go past the public headlines into fuller article history, source cross-checks, and deeper narrative tracking.
Tie news into alerts, watchlists, and conviction changes instead of browsing one static batch of stories.
Buy Value
$0
Sell Value
$2M
Buys
0
Sells
7
Buy Value
$0
Sell Value
$2M
Buy/Sell Ratio
0.00x
After signup
The full app goes deeper on insider behavior
Inspect longer insider history, recurring buyers and sellers, and the broader transaction context beyond this snapshot.
Continue into deeper institutional and alternative-data views once you sign up.
| Date | Name | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-21 | Giroux Richard | Sell | 56,000 | $10.22 |
| 2026-04-17 | EDELMAN JOSEPH | A | 555,555 | $9.00 |
| 2026-04-07 | Naylor Stuart | Sell | 27,661 | $9.36 |
| 2026-03-25 | EDELMAN JOSEPH | A | 300,000 | $0.00 |
| 2026-03-25 | EDELMAN JOSEPH | A | 400,000 | $0.00 |
| 2026-03-25 | EDELMAN JOSEPH | D | 300,000 | $0.00 |
| 2026-03-25 | EDELMAN JOSEPH | D | 400,000 | $0.00 |
| 2026-03-24 | Forbes Alexandria | Sell | 62,000 | $7.41 |
| ETF | Shares | Weight | As Of |
|---|---|---|---|
| iShares Trust-iShares Russell 2000 ETF | 1,108,547 | 0.01% | 2026-02-28 |
| iShares Trust-iShares Biotechnology ETF | 437,916 | 0.01% | 2026-02-28 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 435,373 | 0.01% | 2026-01-31 |
| iShares Trust-iShares Russell 2000 Growth ETF | 283,239 | 0.00% | 2026-02-28 |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 204,936 | 0.00% | 2025-11-30 |
| ROYCE FUND-Royce Smaller-Companies Growth Fund | 176,000 | 0.00% | 2025-12-31 |
| VANGUARD WORLD FUND-Vanguard Health Care Index Fund | 132,477 | 0.00% | 2025-11-30 |
| iShares Trust-iShares Micro-Cap ETF | 118,867 | 0.00% | 2026-02-28 |
After signup
The deeper ownership view shows who is leaning in
Open richer institutional and holder diffs to see position changes across filings instead of one static snapshot.
Use those ownership shifts alongside conviction and alerts in the full app workflow.
Qube Research & Technologies
Filed 2026-02-17
--
--
BlackRock
Filed 2024-05-10
$13M
--
Geode Capital Management
Filed 2025-11-12
$5M
-0.4%
Vanguard Group
Filed 2026-01-29
$4M
+6.6%
Goldman Sachs
Filed 2026-02-10
$4M
+75.5%
D.E. Shaw
Filed 2026-02-17
$3M
+120.4%
Latest Interest
0
Peak Interest
100
After signup
The full trends view adds more narrative depth
Go deeper into related queries, regional interest, and the broader narrative behind retail attention.
Track how that search interest lines up with price moves, alerts, and saved ideas after signup.
4.21
Consensus
Buy—
—
—
14
For informational and educational purposes only. Not financial advice. Learn more
Related reading
Research and strategy guides from the alphactor blog.
Accruals Quality: How to Spot Earnings That Aren't Real
Accruals measure the gap between reported earnings and actual cash. Widening accruals is one of the most reliable red flags in financial analysis — Sloan's…
Altman Z-Score: A Bankruptcy Predictor That Still Works
Edward Altman's 1968 discriminant model predicts bankruptcy within two years about 72% of the time at its distress threshold.
Balance Sheet Deep Dive
Balance sheet changes lead income statements by 2-6 quarters. Net debt, receivables days, and goodwill are the lines that move stocks first.